AIM ImmunoTech, Inc. (AIM)
0.1626
-0.01
(-4.35%)
USD |
NYAM |
Oct 22, 16:00
0.1626
0.00 (0.00%)
After-Hours: 16:33
AIM ImmunoTech Max Drawdown (5Y) : 99.91% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 99.91% |
| August 31, 2026 | 99.90% |
| July 31, 2026 | 99.90% |
| June 30, 2026 | 99.90% |
| May 31, 2026 | 99.90% |
| April 30, 2026 | 99.79% |
| March 31, 2026 | 99.77% |
| February 28, 2026 | 99.72% |
| January 31, 2026 | 99.60% |
| December 31, 2025 | 99.60% |
| November 30, 2025 | 99.54% |
| October 31, 2025 | 99.35% |
| September 30, 2025 | 99.35% |
| August 31, 2025 | 99.35% |
| July 31, 2025 | 99.35% |
| June 30, 2025 | 99.35% |
| May 31, 2025 | 99.35% |
| April 30, 2025 | 99.35% |
| March 31, 2025 | 98.88% |
| February 28, 2025 | 98.88% |
| January 31, 2025 | 99.42% |
| December 31, 2024 | 99.65% |
| November 30, 2024 | 99.75% |
| October 31, 2024 | 99.76% |
| September 30, 2024 | 99.76% |
| Date | Value |
|---|---|
| August 31, 2024 | 99.76% |
| July 31, 2024 | 99.76% |
| June 30, 2024 | 99.76% |
| May 31, 2024 | 99.76% |
| April 30, 2024 | 99.76% |
| March 31, 2024 | 99.76% |
| February 29, 2024 | 99.76% |
| January 31, 2024 | 99.76% |
| December 31, 2023 | 99.76% |
| November 30, 2023 | 99.76% |
| October 31, 2023 | 99.76% |
| September 30, 2023 | 99.76% |
| August 31, 2023 | 99.76% |
| July 31, 2023 | 99.76% |
| June 30, 2023 | 99.76% |
| May 31, 2023 | 99.76% |
| April 30, 2023 | 99.76% |
| March 31, 2023 | 99.76% |
| February 28, 2023 | 99.76% |
| January 31, 2023 | 99.76% |
| December 31, 2022 | 99.76% |
| November 30, 2022 | 99.76% |
| October 31, 2022 | 99.76% |
| September 30, 2022 | 99.76% |
| August 31, 2022 | 99.76% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 77.18% |
| Alnylam Pharmaceuticals, Inc. | 58.17% |
| Anika Therapeutics, Inc. | 83.15% |
| Savara, Inc. | 93.79% |
| Vericel Corp. | 73.97% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -92.06 |
| Beta (5Y) | 1.269 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 104.2% |
| Historical Sharpe Ratio (5Y) | -0.7614 |
| Historical Sortino (5Y) | -1.466 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 44.70% |